课题基金 / 基金详情

INTENSIVE NUTRITION THERAPY IN PATIENTS WITH SICKLE CELL ANEMIA

INTENSIVE NUTRITION THERAPY IN PATIENTS WITH SICKLE CELL ANEMIA
镰状细胞性贫血患者的强化营养治疗
批准号:
6308633
负责人:
PAUL R HARMATZ
金额:
$2.58万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

PAUL R HARMATZ的其他基金

相似基金

相关文献

中文摘要
翻译
生长迟缓在患有镰状细胞病的儿童中很普遍。 这项研究将检验强化营养治疗通过改善营养状况减少镰状细胞病相关的医疗并发症和医疗费用的假设。
英文摘要
Growth retardation is prevalent in children with sickle cell disease. This study will test the hypothesis that intensive nutrition therapy reduces medical complications and cost of medical care associated with sickle cell disease through improved nutrition status.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II MPS
MULTI CENTER, MULTI NATIONAL OPEN LABEL EXTENSION STUDY FOR MPS VI ASB-03-06
VALIDATION OF BIOSUSCEPTOMETRY AS A NON-INVASIVE TECHNIQUE FOR ASSESSMENT OF
A PHASE II OPEN-LABEL CLINICAL STUDY OF EFFICACY AND SAFETY OF RECOMBINANT H
海外基金